Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1983 1
1990 1
1993 1
1994 2
1995 1
1997 1
1998 1
1999 2
2000 2
2001 2
2002 4
2003 1
2004 2
2005 2
2006 3
2007 5
2008 2
2009 2
2010 2
2011 4
2012 1
2013 2
2014 5
2015 3
2017 2
2018 3
2019 5
2020 5
2021 2
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
Chan MY, Efthymios M, Tan SH, Pickering JW, Troughton R, Pemberton C, Ho HH, Prabath JF, Drum CL, Ling LH, Soo WM, Chai SC, Fong A, Oon YY, Loh JP, Lee CH, Foo RSY, Ackers-Johnson MA, Pilbrow A, Richards AM. Chan MY, et al. Among authors: richards am. Circulation. 2020 Oct 13;142(15):1408-1421. doi: 10.1161/CIRCULATIONAHA.119.045158. Epub 2020 Sep 4. Circulation. 2020. PMID: 32885678 Free PMC article. Clinical Trial.
BACKGROUND: Heart failure (HF) is the most common long-term complication of acute myocardial infarction (MI). Understanding plasma proteins associated with post-MI HF and their gene expression may identify new candidates for biomarker and drug target discovery. ...
BACKGROUND: Heart failure (HF) is the most common long-term complication of acute myocardial infarction (MI). Understanding plasma pr …
What we know about cardiomyocyte dedifferentiation.
Zhu Y, Do VD, Richards AM, Foo R. Zhu Y, et al. Among authors: richards am. J Mol Cell Cardiol. 2021 Mar;152:80-91. doi: 10.1016/j.yjmcc.2020.11.016. Epub 2020 Dec 1. J Mol Cell Cardiol. 2021. PMID: 33275936 Free article. Review.
We lack robust molecular markers and proper understanding of the mechanisms driving dedifferentiation. Even the term dedifferentiation is debated because there is no objective evidence of pluripotency, and could rather reflect CM plasticity instead. ...
We lack robust molecular markers and proper understanding of the mechanisms driving dedifferentiation. Even the term dedifferentiatio …
Adrenomedullin and heart failure.
Rademaker MT, Cameron VA, Charles CJ, Lainchbury JG, Nicholls MG, Richards AM. Rademaker MT, et al. Among authors: richards am. Regul Pept. 2003 Apr 15;112(1-3):51-60. doi: 10.1016/s0167-0115(03)00022-3. Regul Pept. 2003. PMID: 12667625 Review.
In heart failure, elevated circulating AM also identifies patients likely to receive long-term benefit from inclusion of additional anti-failure therapy (carvedilol). ...
In heart failure, elevated circulating AM also identifies patients likely to receive long-term benefit from inclusion of additional a …
Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure.
Tan ESJ, Chan SP, Choi YC, Pemberton CJ, Troughton R, Poppe K, Lund M, Devlin G, Doughty RN, Richards AM. Tan ESJ, et al. Among authors: richards am. JACC Heart Fail. 2023 Jun;11(6):662-674. doi: 10.1016/j.jchf.2023.01.016. Epub 2023 Apr 12. JACC Heart Fail. 2023. PMID: 37286261
OBJECTIVES: The authors investigated the regional handling of plasma IGFBP-7 and its association with long-term outcomes in CHF in comparison with selected circulating biomarkers. ...
OBJECTIVES: The authors investigated the regional handling of plasma IGFBP-7 and its association with long-term outcomes in CHF in co …
Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man.
Nicholls MG, Lainchbury JG, Lewis LK, McGregor DO, Richards AM, Troughton RW, Yandle TG. Nicholls MG, et al. Among authors: richards am. Peptides. 2001 Nov;22(11):1745-52. doi: 10.1016/s0196-9781(01)00508-3. Peptides. 2001. PMID: 11754960 Review.
Although much more information is required to clarify the role of AM under physiological and pathophysiological circumstances, it is clear that it has prominent hemodynamic and neurohormonal effects, though generally lesser urinary effects when administered short-term in d …
Although much more information is required to clarify the role of AM under physiological and pathophysiological circumstances, it is clear t …
ST2 in stable and unstable ischemic heart diseases.
Richards AM, Di Somma S, Mueller T. Richards AM, et al. Am J Cardiol. 2015 Apr 2;115(7 Suppl):48B-58B. doi: 10.1016/j.amjcard.2015.01.041. Epub 2015 Jan 23. Am J Cardiol. 2015. PMID: 25678392 Review.
Similar but weaker associations have been reported in non-ST elevation myocardial infarction, in which ST2 predicts short-term (30-day) and long-term (>1-year) death and heart failure independent of clinical indicators, but these relations are lost if Global Regi …
Similar but weaker associations have been reported in non-ST elevation myocardial infarction, in which ST2 predicts short-term (30-da …
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.
González A, Richards AM, de Boer RA, Thum T, Arfsten H, Hülsmann M, Falcao-Pires I, Díez J, Foo RSY, Chan MY, Aimo A, Anene-Nzelu CG, Abdelhamid M, Adamopoulos S, Anker SD, Belenkov Y, Ben Gal T, Cohen-Solal A, Böhm M, Chioncel O, Delgado V, Emdin M, Jankowska EA, Gustafsson F, Hill L, Jaarsma T, Januzzi JL, Jhund PS, Lopatin Y, Lund LH, Metra M, Milicic D, Moura B, Mueller C, Mullens W, Núñez J, Piepoli MF, Rakisheva A, Ristić AD, Rossignol P, Savarese G, Tocchetti CG, Van Linthout S, Volterrani M, Seferovic P, Rosano G, Coats AJS, Bayés-Genís A. González A, et al. Among authors: richards am. Eur J Heart Fail. 2022 Jun;24(6):927-943. doi: 10.1002/ejhf.2493. Epub 2022 Apr 21. Eur J Heart Fail. 2022. PMID: 35334137 Free article. Review.
The geometry, systolic and diastolic function and electric activity of the left ventricle are affected, as well as the left atrium and on the long term even right heart chambers. At a cellular and molecular level, remodelling involves all components of cardiac tissue: card …
The geometry, systolic and diastolic function and electric activity of the left ventricle are affected, as well as the left atrium and on th …
Urotensin II in the cardiovascular system.
Richards AM, Charles C. Richards AM, et al. Peptides. 2004 Oct;25(10):1795-802. doi: 10.1016/j.peptides.2004.04.017. Peptides. 2004. PMID: 15476948 Review.
Initial demonstration of potent vasoconstriction and cardiac depression by the human isoform in non-human primates has been followed by a series of reports indicating potent but highly variable and generally modest vascular responses dependent on species and vascular region. In m …
Initial demonstration of potent vasoconstriction and cardiac depression by the human isoform in non-human primates has been followed by a se …
Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis.
Tan ESJ, Oon YY, Chan SP, Liew OW, Chong JPC, Tay E, Soo WM, Yip JWL, Gong L, Lunaria JB, Yong QW, Lee EM, Yeo DPS, Ding ZP, Tang HC, Ewe SH, Chin CCW, Chai SC, Goh PP, Ling LF, Ong HY, Richards AM, Ling LH. Tan ESJ, et al. Among authors: richards am. Heart. 2022 Jul 27;108(16):1319-1327. doi: 10.1136/heartjnl-2021-320707. Heart. 2022. PMID: 35332049
Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
Neumann JT, Twerenbold R, Ojeda F, Sörensen NA, Chapman AR, Shah ASV, Anand A, Boeddinghaus J, Nestelberger T, Badertscher P, Mokhtari A, Pickering JW, Troughton RW, Greenslade J, Parsonage W, Mueller-Hennessen M, Gori T, Jernberg T, Morris N, Liebetrau C, Hamm C, Katus HA, Münzel T, Landmesser U, Salomaa V, Iacoviello L, Ferrario MM, Giampaoli S, Kee F, Thorand B, Peters A, Borchini R, Jørgensen T, Söderberg S, Sans S, Tunstall-Pedoe H, Kuulasmaa K, Renné T, Lackner KJ, Worster A, Body R, Ekelund U, Kavsak PA, Keller T, Lindahl B, Wild P, Giannitsis E, Than M, Cullen LA, Mills NL, Mueller C, Zeller T, Westermann D, Blankenberg S; COMPASS-MI Study Group. Neumann JT, et al. N Engl J Med. 2019 Jun 27;380(26):2529-2540. doi: 10.1056/NEJMoa1803377. N Engl J Med. 2019. PMID: 31242362
Lower high-sensitivity troponin concentrations at presentation and smaller absolute changes during serial sampling were associated with a lower likelihood of myocardial infarction and a lower short-term risk of cardiovascular events. For example, high-sensitivity troponin …
Lower high-sensitivity troponin concentrations at presentation and smaller absolute changes during serial sampling were associated with a lo …
71 results